CLOV DCF Model
| Dec'20 Actual | Dec'21 Actual | Dec'22 Actual | Dec'23 Actual | Dec'24 Actual | Dec'25 Estimate | Dec'26 Estimate | Dec'27 Estimate | Dec'28 Estimate | Dec'29 Estimate | Dec'30 Estimate | Dec'31 Estimate | Dec'32 Estimate | Dec'33 Estimate | Dec'34 Estimate | Dec'35 Terminal | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 672.9 45.6% | 1,472.0 118.8% | 1,096.6 (25.5%) | 1,260.5 15.0% | 1,371.1 8.8% | 1,864.7 36.0% | 2,201.7 18.1% | 2,498.5 13.5% | 2,735.7 9.5% | 2,984.2 9.1% | 3,225.0 8.1% | 3,452.6 7.1% | 3,661.2 6.0% | 3,845.2 5.0% | 3,999.6 4.0% | 4,119.6 3.0% |
% margin | (92.7) (13.8%) | (637.0) (43.3%) | (286.7) (10.7%) | (205.3) (10.3%) | (45.7) (3.3%) | (276.4) (14.8%) | (326.4) (14.8%) | (370.4) (14.8%) | (405.5) (14.8%) | (442.4) (14.8%) | (478.1) (14.8%) | (511.8) (14.8%) | (542.7) (14.8%) | (570.0) (14.8%) | (592.9) (14.8%) | (610.7) (14.8%) |
NOPAT % effective tax rate | (92.7) (13.8%) | (637.0) (43.3%) | (286.7) (26.1%) | (205.3) (16.3%) | (45.7) (3.3%) | (276.4) (14.8%) | (326.4) (14.8%) | (370.4) (14.8%) | (405.5) (14.8%) | (442.4) (14.8%) | (478.1) (14.8%) | (511.8) (14.8%) | (542.7) (14.8%) | (570.0) (14.8%) | (592.9) (14.8%) | (610.7) (14.8%) |
% of revenue | 0.6 0.1% | 1.2 0.1% | 1.2 0.1% | 2.5 0.2% | 1.3 0.1% | 2.5 0.1% | 3.0 0.1% | 3.4 0.1% | 3.7 0.1% | 4.0 0.1% | 4.3 0.1% | 4.7 0.1% | 4.9 0.1% | 5.2 0.1% | 5.4 0.1% | 5.6 0.1% |
% of revenue | (0.7) (0.1%) | (0.7) (0.0%) | (4.5) (0.4%) | (0.6) (0.0%) | (1.6) (0.1%) | (3.5) (0.2%) | (4.2) (0.2%) | (4.7) (0.2%) | (5.2) (0.2%) | (5.6) (0.2%) | (6.1) (0.2%) | (6.5) (0.2%) | (6.9) (0.2%) | (7.3) (0.2%) | (7.6) (0.2%) | (7.8) (0.2%) |
% of revenue | 4.6 0.7% | 192.7 13.1% | 98.3 9.0% | (55.4) (4.4%) | 12.9 0.9% | 34.2 1.8% | 40.4 1.8% | 45.9 1.8% | 50.2 1.8% | 54.8 1.8% | 59.2 1.8% | 63.4 1.8% | 67.2 1.8% | 70.6 1.8% | 73.4 1.8% | 75.6 1.8% |
Free Cash Flow to Firm (FCFF) % of revenue | (88.2) (13.1%) | (443.8) (30.1%) | (22.0) (2.0%) | (182.8) (14.5%) | (33.1) (2.4%) | (243.2) (13.0%) | (287.2) (13.0%) | (325.9) (13.0%) | (356.8) (13.0%) | (389.2) (13.0%) | (420.6) (13.0%) | (450.3) (13.0%) | (477.5) (13.0%) | (501.5) (13.0%) | (521.7) (13.0%) | (537.3) (13.0%) |
% of FCFF used in calculation | 80.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | ||||||
Discount period | 0.50 | 1.50 | 2.50 | 3.50 | 4.50 | 5.50 | 6.50 | 7.50 | 8.50 | 9.50 | ||||||
Discount factor | 0.95 | 0.85 | 0.77 | 0.69 | 0.62 | 0.56 | 0.50 | 0.45 | 0.41 | 0.37 | ||||||
Discounted FCFF (DFCFF) |
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Low P/E stocks
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
CLOV DCF Value
DCF Value Calculation
Equity Value Bridge
CLOV DCF Financials
CLOV DCF sensitivity
Explore more intrinsic value tools hub for CLOV
FAQ
What is Clover Health Investments, Corp. DCF (discounted cash flow) valuation?
As of Mar 11, 2025, Clover Health Investments, Corp.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by (100.0%) compared to its current price of around $3.4, using a WACC of 11.2% and growth rates of 3.0%.
What is Clover Health Investments, Corp. WACC?
As of Mar 11, 2025, Clover Health Investments, Corp.'s Weighted Average Cost of Capital (WACC) is approximately 11.2%.
What is Clover Health Investments, Corp. Enterprise Value?
As of Mar 11, 2025, Clover Health Investments, Corp.'s Enterprise Value (EV) is approximately $0.0. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.